Superficial Basal Cell Carcinoma

Superficial basal cell carcinoma (sBCC) is the least aggressive form of basal cell carcinoma. Unlike the nodular type, it stays close to the skin surface rather than growing inward, which makes it well suited to non-surgical approaches. It appears most often on the trunk, shoulders, and upper limbs as a flat, slightly scaly, pinkish-red patch, sometimes with a subtle raised border.

Medicine used to treat Superficial Basal Cell Carcinoma

Aldara

Imiquimod

5%

Designed to target viral or abnormal cell lesions and to alleviate site-specific skin conditions.

From $10.13 / sachet View

Treating sBCC without surgery

Because superficial basal cell carcinoma has not invaded deeper tissue, topical agents can clear the lesion without cutting. Imiquimod is an immune-response modifier applied directly to the patch; it prompts the skin’s own defences to target and destroy the abnormal cells. Clearance rates are high when the full course is completed. For broader context on managing skin conditions medically, the skin care category lists related treatments.

Any lesion that bleeds unprompted, changes size rapidly, or fails to respond to topical treatment should be reviewed by a dermatologist, as it may need biopsy or excision.